Combination regimen of nirmatrelvir/ritonavir and molnupiravir for the treatment of persistent SARS-CoV-2 infection: A case report and a scoping review of the literature

Immunocompromised patients still experience unpredictable courses of COVID-19, despite that effective vaccines and drugs against SARS-CoV-2 are now available. Antiviral combination regimens may have a role in SARS-CoV-2 infection in immunocompromised hosts, but current knowledge is still limited. We...

Descripció completa

Dades bibliogràfiques

Autors principals:	Davide Marangoni, Roberta Maria Antonello, Marco Coppi, Marianna Palazzo, Luca Nassi, Noemi Streva, Laura Povolo, Francesca Malentacchi, Lorenzo Zammarchi, Gian Maria Rossolini, Alessandro Maria Vannucchi, Alessandro Bartoloni, Michele Spinicci
Format:	Artigo
Idioma:	Inglês
Publicat:	Elsevier 2023-08-01
Col·lecció:	International Journal of Infectious Diseases
Matèries:	COVID-19 Antiviral Remdesivir Relapsing Association
Accés en línia:	http://www.sciencedirect.com/science/article/pii/S1201971223005465
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!